Bio/Pharmaceutical Outsourcing Report, September 2025
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from GlobalData's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for –
– CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
– Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
– Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
Learn about the past quarter’s M&A and financing deals in the manufacturing space.
Identify the latest contract service agreements.
Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Aenova Holding GmbH
AGC Biologics Inc
Akadeum Life Sciences Inc
Andelyn Biosciences Inc
Amplo Biotechnology Inc
Ardena Holding NV
AstraZeneca Plc
Astellas Pharma Inc
BioFactura Inc
Biogen Inc
Biomay AG
Boehringer Ingelheim Fremont Inc
Boehringer Ingelheim Pharma GmbH & Co KG
Bora Pharmaceuticals Co Ltd
Capitol Biologics
Catalent CTS LLC
Catalent Inc
Charles River Laboratories International Inc
Chiesi Farmaceutici SpA
Cirsium Biosciences Inc
Corden Pharma International GmbH
Cytovance Biologics Inc
DGr Pharma BV
Eli Lilly and Co
Esteve Pharmaceuticals SA
Esteve Quimica SA
Exothera
Famar Health Care Services
Flamma SpA
Forge Biologics Inc
FUJIFILM Biotechnologies USA Inc
GSK (GlaxoSmithKline)
Genentech Inc
Johnson & Johnson
Kyowa Kirin Co Ltd
Lotte Biologics Co Ltd
Made Scientific Inc
Maxona Pharmaceuticals Inc
Merck & Co Inc
Neurosense Therapeutics Ltd
Nelson Laboratories LLC
NewAmsterdam Pharma
NextPharma Technologies Holding Ltd
Northwest Biotherapeutics Inc
Organon & Co
Oxford BioMedica Plc
Pace Analytical Services LLC
Patheon NV
Pfizer Ltd
Piramal Pharma Solutions Inc
Quratis Inc
Recipharm
Recipharm AB
ROVI Pharma Industrial Services SA
Rottendorf Pharma GmbH
Samsung Biologics Co Ltd
Sanofi
Siegfried Holding AG
Simtra US LLC
Snapdragon Chemistry Inc
Tonix Pharmaceuticals Inc
Vetter Pharma-Fertigung GmbH & Co KG
Wisconsin Pharmacal Co LLC
WuXi Biologics Ireland Ltd
WuXi STA (Shanghai) Co Ltd
WuXi XDC Cayman Inc
Table of Contents
Table
Figures
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Contract Manufacturers reports